Voluntary Disclosure Announcement on the Approval of Marketing Application for New Indications of Xeligekimab

About this update from Chongqing Genrix Biopharmaceutical Co., Ltd. Class A

Voluntary Disclosure Announcement on Approval of Marketing Application for New Indication of Xeligekimab The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Chongqing Genrix Biopharmaceutical Co., Ltd. Class A